Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2007
11/15/2007WO2003086313A3 Methods for lightening skin and hair
11/15/2007WO2003018754A3 Neural regeneration peptide and methods for their use in treatment of brain damage
11/15/2007WO2003000840A3 Nitrilases
11/15/2007WO2001055313A3 Nucleic acids, proteins, and antibodies
11/15/2007US20070266458 Isolated Polynucleotide Molecules Corresponding to Mutant and Wild-Type Alleles of the Maize D9 Gene and Methods of Use
11/15/2007US20070266456 Methods and compositions for obtaining marker-free transgenic plants
11/15/2007US20070265514 Systems and methods for calibrating minimally invasive and non-invasive physiological sensor devices
11/15/2007US20070265451 Process for the preparation of oxazolidinones and method of use thereof
11/15/2007US20070265435 Process for the synthesis of oligomeric compounds
11/15/2007US20070265341 Compositions and methods for treating eye disorders and conditions
11/15/2007US20070265240 Sequence Selective Pyrrole and Imidazole Polyamide Metallocomplexes
11/15/2007US20070265220 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
11/15/2007US20070265219 Modulation of thyroid hormone receptor interactor 3 expression
11/15/2007US20070265218 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
11/15/2007US20070265217 Single Nucleotide Polymorphisms as Prognostic Tool to Diagnose Adverse Drug Reactions (Adr) and Drug Efficacy
11/15/2007US20070265216 Enhanced medical treatment in diabetic cardiomyopathy
11/15/2007US20070265198 Nucleic Acids and Polypeptides of C1 Bacteriophage and Uses Thereof
11/15/2007US20070265188 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
11/15/2007US20070265186 Biotin-Facilitated Transport in Gram Negative Bacteria
11/15/2007US20070265164 Active Substances for Increasing Pathogenic Defense in Plants and Methods for the Detection Thereof
11/15/2007US20070264717 Method of Classifying Chemical Agents and Identifying Cellular Targets Thereof
11/15/2007US20070264709 pluripotent cell comprising a sequence encoding a selectable marker operatively linked to a promoter of a gene selected from the group consisting of sox-1, sox-2, sox-3, Pax 3, delta-1, Mash-1, Math 4a, Pax 6, beta 3-tubulin, synapsin-1, MAP2/tau, GFAP, GABA and islet-1/2
11/15/2007US20070264699 Method for cyrstallizing human GSK3 and novel crystal structure thereof
11/15/2007US20070264698 Information rich libraries
11/15/2007US20070264693 Hyphal growth in fungi
11/15/2007US20070264692 producing the hybrid proteins comprising a single polypeptide having a target protein with a ligand-dependent intein embedded in the sequence of target proteins; modulation of protein activity; molecular switches
11/15/2007US20070264686 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide; cancer treatment
11/15/2007US20070264683 Process challenge device for a high-pressure steam sterilizer and sheet for a challenge device
11/15/2007US20070264682 Cell culture model and applications thereof
11/15/2007US20070264681 Determining the transition between different phases of the cell cycle in mammalian cells; non-destructive
11/15/2007US20070264680 Method and Test-Kit for the Detection and Quantification of Organisms
11/15/2007US20070264679 Method for analyzing the activity of lipoxygenase using a water-soluble substrate
11/15/2007US20070264678 Using resonance energy transfer to characterize molecular interactions of kinase; rational drug design
11/15/2007US20070264677 Methods, systems and computer programs for assessing chd risk using adjusted hdl particle number measurements
11/15/2007US20070264675 Microfluidic device for cell separation and uses thereof
11/15/2007US20070264671 Diagnosis and prognosis of dipeptidyl peptidase-associated disease states
11/15/2007US20070264667 Method and system for assaying transferase activity
11/15/2007US20070264666 High density sequence detection methods
11/15/2007US20070264665 Nonseparation assay methods
11/15/2007US20070264664 Nonseparation assay methods
11/15/2007US20070264663 Methods and reagents for detecting susceptibility to graft versus host disease or transplant related mortality
11/15/2007US20070264662 Polynucleotides encoding human SLAP-2 variants, hSLAP-2v3 and hSLAP-2v4
11/15/2007US20070264661 Method for rapid identification of molecules with functional activity towards biomolecular targets
11/15/2007US20070264660 Dna replication factors
11/15/2007US20070264659 Lung cancer biomarker discovery
11/15/2007US20070264658 Compositions and methods to detect enterococci nucleic acid
11/15/2007US20070264657 Probe sets for detecting MYC-immunoglobulin gene rearrangements
11/15/2007US20070264656 Method of manufacturing probe-immobilized carrier
11/15/2007US20070264655 Nucleic acid automatic examining device
11/15/2007US20070264654 Methods for identifying polypeptide targets and uses thereof for treating immunological diseases
11/15/2007US20070264653 Method of identifying a biological sample for methylation analysis
11/15/2007US20070264652 Method for detection of a sequence
11/15/2007US20070264651 Methods, compositions, and kits for the detection and monitoring of kidney cancer
11/15/2007US20070264650 Universal fieldable assay with unassisted visual detection
11/15/2007US20070264649 building up magnetic field gradient along flow direction and a heat transfer perpendicular to flow; magnetic field is focused by Mumetal.RTM. which is arranged on both sides of the flow channel and the temperature is controlled by way of Peltier elements, cooling bodies, and thermal coupling plates
11/15/2007US20070264648 Dna Oligomer, Genetic Marker and Dna Oligomer Set for Prediction of Onset of Side-Effect from Radiation Therapy, and Method for Predicting Onset of Side-Effect
11/15/2007US20070264647 Using stannous halide stabilized and/or enhanced alkaline solutions to stabilize hydrogen peroxide at a pH greater than 7.0; higher shelf-life and provide enhanced detection of the subject analyte
11/15/2007US20070264646 Hbv Particles Containing Hbv-Rna
11/15/2007US20070264645 Using allelic variation in interleukin-1 gene as evaluative tool in diagnosing inflammatory disorders; predicting interleukin-1 protein expression
11/15/2007US20070264644 Method for distinguishing between head and neck squamous cell carcinoma and lung squamous cell carcinoma
11/15/2007US20070264643 Compositions and Methods Relating to CNS Lymphoma
11/15/2007US20070264642 Direct multiplex characterization of genomic DNA
11/15/2007US20070264641 Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection
11/15/2007US20070264640 Array-based assays using split-probe nucleic acid arrays
11/15/2007US20070264639 Identification of Echinacea and its imposters using genetic variations
11/15/2007US20070264638 Identification of ginseng and its imposters using genetic variations
11/15/2007US20070264637 11q DELETION AS A MOLECULAR GENETIC MARKER IN BREAST CANCER
11/15/2007US20070264636 Capture and random amplification protocol for identification and monitoring of microbial diversity
11/15/2007US20070264635 Probe, probe set and information acquisition method using the same
11/15/2007US20070264634 Contacting nanowires with a solution comprising the component of interest; binding the component of interest to the central portion of the hairpin oligonucleotide unfolds the hairpin, thereby moving the charge moiety away from the nanowires, producing the change in charge, detecting the signal
11/15/2007US20070264633 Dutp Based Compositions for Reducing Primer-Aggregate Formations During Nucleic Acid Amplification
11/15/2007US20070264632 contacting the sample with a suicide substrate that covalently modifies a terpene synthase, results in covalent binding of the substrate to an amino acid of the enzyme to form a covalently modified enzyme; determining an amino acid sequence of at least a portion of the covalently modified enzyme
11/15/2007US20070264631 Using allelic profile of human insulin receptor substrate 2 gene as evaluative tool in prediciting vesnarinone induced reduction in blood granulocytes
11/15/2007US20070264630 Liquid DNA sample to be analyzed is guided over a DNA chip in a defined time course; after hybridization, temperature is modified such that scavenger/target DNA hybrids are melted, DNA hybrids is detected and evaluated, simplification
11/15/2007US20070264629 Real-Time Detection of Influenza Virus
11/15/2007US20070264628 Phase transition type valve and method of manufacturing the same
11/15/2007US20070264627 Retrovirus from the HIV group and its use
11/15/2007US20070264626 Apparatus and Method for a Combination of Ablative and Nonablative Dermatological Treatment
11/15/2007US20070264625 Apparatus and Method for Ablation-Related Dermatological Treatment of Selected Targets
11/15/2007US20070264624 Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same
11/15/2007US20070264623 Nanosensors
11/15/2007US20070264408 testing the DNA in its milk of the bovine animal; for identifying a physical trait of an animal, determine the cow has the absence of the beta -casein A1 protein or the percentage of saturated fats
11/15/2007US20070264284 Therapeutic, Prophylactic and Diagnostic Agents for Hepatitis B
11/15/2007US20070264282 Herpes virus strains for gene therapy
11/15/2007US20070264272 Assessment and reduction of risk of graft-versus-host disease
11/15/2007US20070264268 screening for somatomedin receptor modulators comprising contacting a mannoside polypeptide or nucleic acid bioassay with a test agent and detecting the test agents biased activity of the bioassay; drug screening; animal models
11/15/2007US20070264267 Nucleotide sequences coding zinc transport protein for use in diagnosis, prevention and treatment of cell proliferative disorders
11/15/2007US20070264261 Methods of Therapy and Diagnosis Using Targeting of Cells that Express Killer Cell Immunoglobulin like Receptor like Proteins
11/15/2007US20070264251 C1q Related Protein
11/15/2007US20070264197 Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection reagents
11/15/2007US20070264196 Modulators of ATP-binding cassette transporters
11/15/2007US20070264194 Peptides That Bind To Atherosclerotic Lesions
11/15/2007US20070264193 Diagnostics and treatments for tumors
11/15/2007US20070264191 Materials and Methods Relating to the Treatment of Glioblastomas
11/15/2007DE10342274B4 Identifizieren pharmazeutischer Targets Identifying pharmaceutical targets
11/15/2007DE102007021805A1 Assay method comprises an enzyme reaction in which hydrogen peroxide is formed by conversion of an endogenous calibrator, and a immunoassay reaction in which a labeling enzyme uses part of the peroxide for signal generation
11/15/2007DE102006021761A1 Biomolekulare Recheneinheit Biomolecular computing unit
11/15/2007DE102006021493A1 Massenspektrometrische Messung mikrobieller Resistenzen Mass spectrometric measurement of microbial resistance
11/15/2007DE102006020131A1 Nano- und mikrostrukturierter Biosensor und Verfahren zu seiner Herstellung Nano- and microstructured biosensor and method for its manufacture
11/15/2007DE10100581B4 Verfahren und Vorrichtung zum Nachweis von Mikroorganismen auf Oberflächen Method and apparatus for detecting microorganisms on surfaces